Milwaukee, WI, United States of America

Yibin Wang

This inventor holds 2 USPTO granted patents. Top assignee: Uwm Research Foundation, Inc.. Active years: 2014-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yibin Wang. Retrieved from https://idiyas.com/inventor/yibin-wang-ppytntk4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yibin Wang: Innovator in Anti-Cancer Research

Introduction

Yibin Wang is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of cancer research, particularly in the development of anti-cancer agents. With a total of 2 patents, his work focuses on creating compounds that can be selectively activated to target tumor cells.

Latest Patents

Yibin Wang's latest patents revolve around anti-cancer agents. These patents describe compounds that may be selectively activated to produce active anti-cancer agents specifically in tumor cells. Additionally, the patents disclose pharmaceutical compositions that comprise these compounds, along with methods for treating cancer using them.

Career Highlights

Yibin Wang is associated with the UWM Research Foundation, Inc., where he continues to advance his research in cancer treatment. His innovative approach to developing targeted therapies has the potential to improve treatment outcomes for cancer patients.

Collaborations

Yibin Wang has collaborated with notable colleagues in his field, including Xiaohua Peng and Yunyan Kuang. These collaborations enhance the research efforts and contribute to the development of effective cancer therapies.

Conclusion

Yibin Wang's work in anti-cancer research exemplifies the impact of innovation in medicine. His patents and ongoing research hold promise for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…